FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2802961857> ?p ?o ?g. }

• W2802961857 abstract "Skeletal metastases often occur in men with castration-resistant prostate cancer (CRPC) where bone biomarkers are prognostic for overall survival (OS). In those with highly elevated markers, there is preferential benefit from bone-targeted therapy. In the phase IIIS0421 docetaxel +/- atrasentan trial, clinical covariates and bone biomarkers were analyzed to identify CRPC subsets with differential outcomes.Markers of bone resorption [N-telopeptide-NTx; pyridinoline-PYD] and formation [C-terminal collagen propeptide-CICP; bone alkaline phosphatase-BAP] were measured in pre-treatment sera. Bone biomarkers and clinical covariates were included in a Cox model for OS; bone markers were added in a stepwise selection process. Receiver operating characteristic (ROC) curves were constructed for risk factor models +/- bone markers. Significant variables were allowed to compete in a classification and regression tree (CART) analysis. Hazard ratios(HR) were calculated by comparing OS in each of the terminal nodes to a reference group in a Cox model.750 patients were included. Each bone marker significantly contributed to the risk factor-adjusted OS Cox model, with higher levels associated with worse OS. BAP (HR = 1.15, p = 0.008), CICP (HR = 1.27, p < 0.001), and PYD (HR = 1.21, p = 0.047) in combination were significantly associated with OS. Prognostic accuracy was improved by addition of bone markers to clinical covariates. CART analysis selected CICP, BAP, hemoglobin, and pain score for the final OS model, identifying five prognostic groups.Elevated serum bone biomarker levels are associated with worse OS in bone-metastatic CRPC. Bone biomarkers can identify unique prognostic subgroups. These results further define the role of bone biomarkers in the design of CRPC trials." @default.
• W2802961857 created "2018-05-17" @default.
• W2802961857 creator A5001783218 @default.
• W2802961857 creator A5010265482 @default.
• W2802961857 creator A5015887484 @default.
• W2802961857 creator A5023937607 @default.
• W2802961857 creator A5026563364 @default.
• W2802961857 creator A5026675839 @default.
• W2802961857 creator A5026692219 @default.
• W2802961857 creator A5031088617 @default.
• W2802961857 creator A5041002400 @default.
• W2802961857 creator A5041043417 @default.
• W2802961857 creator A5041126882 @default.
• W2802961857 creator A5049622431 @default.
• W2802961857 creator A5059219836 @default.
• W2802961857 creator A5063697466 @default.
• W2802961857 creator A5075799959 @default.
• W2802961857 date "2018-01-01" @default.
• W2802961857 modified "2023-10-17" @default.
• W2802961857 title "Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421" @default.
• W2802961857 cites W1848925583 @default.
• W2802961857 cites W1976146809 @default.
• W2802961857 cites W2020274336 @default.
• W2802961857 cites W2088982930 @default.
• W2802961857 cites W2095384504 @default.
• W2802961857 cites W2113046540 @default.
• W2802961857 cites W2139860898 @default.
• W2802961857 cites W2144517754 @default.
• W2802961857 cites W2145920882 @default.
• W2802961857 cites W2146661251 @default.
• W2802961857 cites W2166775256 @default.
• W2802961857 cites W2329854847 @default.
• W2802961857 cites W2510940971 @default.
• W2802961857 cites W2511755939 @default.
• W2802961857 cites W2567342709 @default.
• W2802961857 cites W2570618306 @default.
• W2802961857 cites W2588172683 @default.
• W2802961857 cites W2607665721 @default.
• W2802961857 cites W4247361750 @default.
• W2802961857 doi "https://doi.org/10.1016/j.ctarc.2018.04.005" @default.
• W2802961857 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6628720" @default.
• W2802961857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31298998" @default.
• W2802961857 hasPublicationYear "2018" @default.
• W2802961857 type Work @default.
• W2802961857 sameAs 2802961857 @default.
• W2802961857 citedByCount "3" @default.
• W2802961857 countsByYear W28029618572020 @default.
• W2802961857 countsByYear W28029618572021 @default.
• W2802961857 countsByYear W28029618572023 @default.
• W2802961857 crossrefType "journal-article" @default.
• W2802961857 hasAuthorship W2802961857A5001783218 @default.
• W2802961857 hasAuthorship W2802961857A5010265482 @default.
• W2802961857 hasAuthorship W2802961857A5015887484 @default.
• W2802961857 hasAuthorship W2802961857A5023937607 @default.
• W2802961857 hasAuthorship W2802961857A5026563364 @default.
• W2802961857 hasAuthorship W2802961857A5026675839 @default.
• W2802961857 hasAuthorship W2802961857A5026692219 @default.
• W2802961857 hasAuthorship W2802961857A5031088617 @default.
• W2802961857 hasAuthorship W2802961857A5041002400 @default.
• W2802961857 hasAuthorship W2802961857A5041043417 @default.
• W2802961857 hasAuthorship W2802961857A5041126882 @default.
• W2802961857 hasAuthorship W2802961857A5049622431 @default.
• W2802961857 hasAuthorship W2802961857A5059219836 @default.
• W2802961857 hasAuthorship W2802961857A5063697466 @default.
• W2802961857 hasAuthorship W2802961857A5075799959 @default.
• W2802961857 hasBestOaLocation W28029618572 @default.
• W2802961857 hasConcept C121608353 @default.
• W2802961857 hasConcept C125870589 @default.
• W2802961857 hasConcept C126322002 @default.
• W2802961857 hasConcept C131075544 @default.
• W2802961857 hasConcept C143998085 @default.
• W2802961857 hasConcept C160160445 @default.
• W2802961857 hasConcept C170033053 @default.
• W2802961857 hasConcept C181199279 @default.
• W2802961857 hasConcept C207103383 @default.
• W2802961857 hasConcept C2777783956 @default.
• W2802961857 hasConcept C2778588143 @default.
• W2802961857 hasConcept C2780192828 @default.
• W2802961857 hasConcept C2780787237 @default.
• W2802961857 hasConcept C2781197716 @default.
• W2802961857 hasConcept C44249647 @default.
• W2802961857 hasConcept C50382708 @default.
• W2802961857 hasConcept C55493867 @default.
• W2802961857 hasConcept C673006 @default.
• W2802961857 hasConcept C71924100 @default.
• W2802961857 hasConcept C86803240 @default.
• W2802961857 hasConceptScore W2802961857C121608353 @default.
• W2802961857 hasConceptScore W2802961857C125870589 @default.
• W2802961857 hasConceptScore W2802961857C126322002 @default.
• W2802961857 hasConceptScore W2802961857C131075544 @default.
• W2802961857 hasConceptScore W2802961857C143998085 @default.
• W2802961857 hasConceptScore W2802961857C160160445 @default.
• W2802961857 hasConceptScore W2802961857C170033053 @default.
• W2802961857 hasConceptScore W2802961857C181199279 @default.
• W2802961857 hasConceptScore W2802961857C207103383 @default.
• W2802961857 hasConceptScore W2802961857C2777783956 @default.
• W2802961857 hasConceptScore W2802961857C2778588143 @default.
• W2802961857 hasConceptScore W2802961857C2780192828 @default.
• W2802961857 hasConceptScore W2802961857C2780787237 @default.
• W2802961857 hasConceptScore W2802961857C2781197716 @default.

• next